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Mammographic breast cancer screening has reduced 
the mortality from breast cancer in the screened 
population by up to 65%.[1] Most First-World 
countries have therefore introduced mammographic 
screening programmes. Plans are afoot to establish 
mammographic screening in ‘resource-enhanced’ settings in 
the developing world, including in northern African countries 
such as Tunisia[2] and Egypt.[3,4] We present an analysis of the first 
mammographic screening pilot programme in sub-Saharan Africa.
Methods 
Patients of screening age (≥40 years) were identified at three 
primary healthcare (PHC) centres in the Cape metropolitan area. 
The women were then informed about the benefits and risks 
of screening and underwent mammography. Mammography 
was performed by certified mammographers in a mobile breast-
screening unit run by a corporate social responsibility organisation 
(Pink Drive, Cause Marketing Fundraisers Pty Ltd, Johannesburg, 
South Africa). The unit was equipped with a Giotto mammography 
machine (Internazionale Medico Scientifica, Italy); the images were 
processed in a Konica computed radiography processor (Konica 
Corporation, Japan) and printed onto discs. Discs were then batch-
read at a private radiology practice by one of two radiologists and 
classified according to the American College of Radiology Breast 
Imaging Reporting and Data System (BIRADS).[5] Those women 
whose mammograms were reported as BIRADS 3 - 5 were referred 
to a tertiary centre for further work-up where the mammograms 
were entered into a picture archiving and communication system 
and reviewed by a team of experienced breast surgeons and 
radiologists, and a management plan was established. For patients 
with confirmed malignancy, the following data were recorded: age 
of the patient; stage of the cancer according to the TNM staging 
system;[6] type of cancer; and further management. Cancers were 
regarded as symptomatic if the patient had sought the attention 
of the PHC centre for a mass in the breast, and true screening if 
the patient had visited the PHC centre for unrelated reasons or for 
breast cancer screening specifically. 
Results 
Between 1 February 2011 and 31 August 2012, 2 732 mammograms 
were performed. Following technical failure of the mammography 
machine, no mammography was performed in April and May 2011. 
Of the total, eight patients were aged <40 years and excluded from 
the analysis. With the remaining 2 724 mammograms, 12 were done 
in women presenting for a mass in the breast, leaving a total of 2 712 
screening mammograms for analysis. Of the mammograms referred 
for further work-up to the tertiary centre, 51 done on patients at 
the beginning of the series were regarded as of such poor quality 
that they were not suitable for interpretation, and the patients had 
repeat mammography performed. Eleven mammograms were not 
made available for review and 14 patients could not be contacted to 
return for work-up; these women were not seen at the tertiary centre 
for further evaluation. Upon review of the 250 available screening 
mammograms, 58 (23%) were rated ‘benign’ or ‘no abnormalities’ 
(BIRADS 1 and 2) and no further action was taken. For the entire 
series of screening mammograms (N=2 712) the cancer diagnosis rate 
was 3.7/1 000 examinations. Of 10 cancers diagnosed at screening, 5 
were TNM clinical stage 0, 2 stage I and 3 stage II. 
The number of mammograms and the biopsy outcome is reflected 
in Table 1. 
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Background. Mammographic screening programmes are now established in developing countries. We present an analysis of the first 
screening programme in sub-Saharan Africa. 
Methods. Women aged ≥40 years were identified at three primary healthcare centres in the Western Cape Province, South Africa, and after 
giving informed consent underwent mammography at a mobile unit. After a single reading, patients with American College of Radiology 
Breast Imaging Reporting and Data System (BIRADS) 3 - 5 lesions were referred to a tertiary centre for further management. 
Results. Between 1 February 2011 and 31 August 2012, 2  712 screening mammograms were performed. A total of 261 screening 
mammograms were reported as BIRADS 3 - 5 (recall rate 9.6%). Upon review of the 250 available screening mammograms, 58 (23%) were 
rated benign or no abnormalities (BIRADS 1 and 2) and no further action was taken. In 32 women, tissue was acquired (biopsy rate for the 
series 1.2%); 10 cancers were diagnosed (biopsy malignancy rate 31%). For the entire series of 2 712 screening mammograms, the cancer 
diagnosis rate was 3.7/1 000 examinations. Of 10 cancers diagnosed at screening, 5 were TNM clinical stage 0, 2 stage I and 3 stage II.
Conclusions. The low cancer detection rate achieved, and the technical and multiple administrative problems experienced do not justify 
installation of a screening programme using the model utilised in this series. 
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Discussion 
Two North African mammographic screening programmes from 
Tunisia illustrate the difficulties of mammographic screening in 
a developing country: a low participation rate; and performance 
indicators falling short of the established screening programmes 
in Europe.[2,7] The methods employed, however, seem to have been 
sound; as illustrated, for example, by the employment of double 
reading and collection of data for key performance indicators. We 
are not aware of any report on the Egyptian screening effort in 
the accessible scientific literature. The mammographic screening 
programme described in this paper is best classified as ‘opportunistic’ 
or ‘community’ screening as it does not fulfil a number of the 
essential criteria for ‘organised’ screening as described by the World 
Health Organization.[8] Multiple areas of concern arise out of the large 
number of mammograms deemed unsuitable for screening purposes: 
the technology used by the screening effort was not appropriate for 
mass screening; and the transfer of images between different systems 
may have compromised image quality. (An improvement in the image 
quality was noted after radiographers from the tertiary centre visited 
the mobile unit and corrected radiographic technique, but quality 
still did not reach standards expected of modern digital systems.) As 
the authors saw only mammograms referred to the tertiary centre 
for work-up, questions remain concerning the quality of the 90.4% 
of mammograms reported as BIRADS 1 and 2 and consequently 
not seen at the tertiary centre. Several factors cast doubt on the 
quality of mammography reading: the lack of image quality was not 
recognised and corrected by the primary readers of the screening 
mammograms; a large number referred patients’ mammograms 
were re-reported as BIRADS 2 (benign finding) when read by the 
experienced team at the referral hospital; and the cancer diagnosis 
rate was far lower than achieved in a tertiary centre in a similar 
population and reported by a private clinic in the same geographical 
area. While inter-observer variation is a well-documented reality 
of mammographic screening,[9] the large variation in this series, 
especially with respect to clinical management implications, is 
concerning. A reason may be the lack of a second reading, which 
is an essential part of mammographic screening programmes. A 
hallmark of a successful screening programme is the diagnosis of 
early cancers, as evidenced by a high proportion of in-situ cancers, 
a high proportion of node-negative cancers and a high proportion 
of infiltrating cancers <1  cm in diameter. Based on the experience 
of the two other series reported from the same area,[10,11] we would 
have expected about 20 - 25 breast cancers to be diagnosed in the 
2 712 asymptomatic women screened in this series. With the low 
number of cancers diagnosed in this screening programme, any 
comments on this central aspect of mammographic screening are 
pure speculation. A final critical concern is that 11 mammograms 
(4.4% of the screening mammograms read as BIRADS 3 - 5) were 
not received by the tertiary centre. This indicates serious deficiencies 
in the administration of the programme and constitutes a major 
potential medico-legal liability. Breast cancer screening, as performed 
in this series, cannot be supported in a resource-limited environment 
such as our own and elsewhere in sub-Saharan Africa. 
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Table 1. Mammograms and biopsy outcome
Mammograms
Total, N 2 712
Age group (years), n (%)
40 - 49 1 062 (39)
50 - 69 1 509 (55)
≥70 141 (5.2)
Recall, n (% of all mammograms) 261 (9.6)
Biopsies, n (% of all mammograms) 32 (1.2)
Cancers diagnosed, n (% of biopsies) 10 (31)
